Related Experiment Video
Updated: Jun 30, 2026
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Pre- and post-natal treatment of hemophagocytic lymphohistiocytosis
Ami J Shah1, Neena Kapoor, Robert M Cooper
1Division of Research Immunology, Childrens Hospital Los Angeles, California 90027, USA. ashah@chla.usc.edu
Hemophagocytic lymphohistiocytosis (HLH) is a rare autosomal recessive disorder of infancy and childhood that is invariably fatal if not treated. We report on the first patient to receive post-natal HSCT for HLH after receiving in utero chemotherapy for disease stabilization.
Hemophagocytic lymphohistiocytosis (HLH) is a rare autosomal recessive disorder of infancy and childhood that is invariably fatal if not treated. We report on the first patient to receive post-natal HSCT for HLH after receiving in utero chemotherapy for disease stabilization.
